92 related articles for article (PubMed ID: 21319958)
21. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
22. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
Pfeiffer E; Hildebrand A; Mikula H; Metzler M
Mol Nutr Food Res; 2010 Oct; 54(10):1468-76. PubMed ID: 20397195
[TBL] [Abstract][Full Text] [Related]
24. Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5'-diphosphate glucuronosyltransferases.
Mackenzie PI; Rodbourn L; Iyanagi T
Cancer Res; 1993 Apr; 53(7):1529-33. PubMed ID: 8453618
[TBL] [Abstract][Full Text] [Related]
25. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
Hoehle SI; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
[TBL] [Abstract][Full Text] [Related]
26. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.
Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J
Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487
[TBL] [Abstract][Full Text] [Related]
29. Characterization of UDP-glucuronosyltransferases involved in glucuronidation of diethylstilbestrol in human liver and intestine.
Zhu L; Ge G; Liu Y; Guo Z; Peng C; Zhang F; Cao Y; Wu J; Fang Z; Liang X; Yang L
Chem Res Toxicol; 2012 Dec; 25(12):2663-9. PubMed ID: 23126256
[TBL] [Abstract][Full Text] [Related]
30. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
Aprile S; Del Grosso E; Grosa G
Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
[TBL] [Abstract][Full Text] [Related]
31. Human UGT2B7 catalyzes morphine glucuronidation.
Coffman BL; Rios GR; King CD; Tephly TR
Drug Metab Dispos; 1997 Jan; 25(1):1-4. PubMed ID: 9010622
[TBL] [Abstract][Full Text] [Related]
32. 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7.
Samokyszyn VM; Gall WE; Zawada G; Freyaldenhoven MA; Chen G; Mackenzie PI; Tephly TR; Radominska-Pandya A
J Biol Chem; 2000 Mar; 275(10):6908-14. PubMed ID: 10702251
[TBL] [Abstract][Full Text] [Related]
33. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
[TBL] [Abstract][Full Text] [Related]
34. Investigation into UDP-glucuronosyltransferase (UGT) enzyme kinetics of imidazole- and triazole-containing antifungal drugs in human liver microsomes and recombinant UGT enzymes.
Bourcier K; Hyland R; Kempshall S; Jones R; Maximilien J; Irvine N; Jones B
Drug Metab Dispos; 2010 Jun; 38(6):923-9. PubMed ID: 20304965
[TBL] [Abstract][Full Text] [Related]
35. Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs.
Foti RS; Fisher MB
Forensic Sci Int; 2005 Oct; 153(2-3):109-16. PubMed ID: 16139098
[TBL] [Abstract][Full Text] [Related]
36. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
37. 13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases.
Jude AR; Little JM; Bull AW; Podgorski I; Radominska-Pandya A
Drug Metab Dispos; 2001 May; 29(5):652-5. PubMed ID: 11302930
[TBL] [Abstract][Full Text] [Related]
38. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
Lépine J; Bernard O; Plante M; Têtu B; Pelletier G; Labrie F; Bélanger A; Guillemette C
J Clin Endocrinol Metab; 2004 Oct; 89(10):5222-32. PubMed ID: 15472229
[TBL] [Abstract][Full Text] [Related]
39. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro.
Mast N; Fotinich A; Pikuleva IA
Drug Metab Dispos; 2022 Jul; 50(7):923-930. PubMed ID: 35489779
[TBL] [Abstract][Full Text] [Related]
40. (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7.
Patel M; Tang BK; Kalow W
Pharmacogenetics; 1995 Feb; 5(1):43-9. PubMed ID: 7773302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
